Review proposes reframing obesity in aging people with HIV around sarcopenic obesity, muscle quality and frailty
This review argues that obesity in aging people with HIV should be treated as a body composition and functional health problem, not simply excess weight, and highlights sarcopenic obesity, muscle quality and frailty. [1]
Automatic summary · not editorially reviewed
The key findings
The review examines evidence for shifting from weight-centric approaches to a framework centered on sarcopenic obesity, muscle quality and frailty in aging people with HIV. [1]
Sarcopenic obesity is described as excess adiposity coexisting with impaired muscle mass or function, and myosteatosis and impaired muscle quality are named as possible mechanistic links to functional decline. [1]
Exercise-based interventions, particularly with resistance training, are said to show promise, while pharmacologic weight loss may raise concerns about lean tissue preservation without a concurrent focus on muscle health. [1]
The source at a glance
- Study type / format
- Review (abstract only)
- Population / context
- Aging people with HIV
- Summary based on
- Study abstract
- Original publication
- September 1, 2026
Review's proposed shift for aging people with HIV
The review notes that obesity is increasingly prevalent as people with HIV age, but that body weight alone does not adequately capture the functional and metabolic consequences of adverse changes in body composition. It therefore examines emerging evidence for moving away from weight-centric approaches toward a framework centered on sarcopenic obesity, muscle quality and frailty in this population.
Supporting source [1]
Visceral fat, sarcopenic obesity and muscle quality
According to the review, weight gain in the contemporary antiretroviral therapy era often reflects increased visceral and ectopic fat. Sarcopenic obesity is described as a clinically relevant phenotype in which excess adiposity coexists with impaired muscle mass or function, with implications for healthy aging. Emerging evidence points to myosteatosis and impaired muscle quality as possible mechanistic links between adiposity and functional decline.
Supporting source [1]
Exercise promise, weight-loss concerns and review scope
Exercise-based interventions, especially those including resistance training, are said to show promise for preserving physical function, reducing frailty and improving body composition. By contrast, pharmacologic weight loss may raise concerns about preserving lean tissue if muscle health is not addressed at the same time. The review concludes that clinical and research priorities should emphasize early identification of vulnerability, preservation of muscle health and interventions supporting long-term physical resilience and independence.
Supporting source [1]
How to interpret this
This is an abstract of a review; the full text was not reviewed. The abstract reports no study design details, sample sizes, follow-up or numerical results, and the described evidence is characterized as emerging. Statements about exercise and pharmacologic weight loss are framed as promise and concerns, not as demonstrated causal effects.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Oliveira VHF, Brown TT, Erlandson KM. · europepmc.org · September 1, 2026